International position statement issued on inpatient CGM and insulin pump use
A newly published international position statement addresses practical use of continuous glucose monitoring, insulin pumps, and automated insulin delivery systems in hospitalized adults who are not critically ill. It covers patient selection criteria, glycemic metrics and goals, insulin titration and administration, perioperative care, CGM alarm settings, staff training, electronic health record integration, imaging considerations, and discharge planning. The statement was developed to address what the authors describe as an urgent and unmet need for practical guidance on these devices in hospital settings.
Most relevant for: Non-critically ill hospitalized adults with diabetes who use or could use continuous glucose monitors, insulin pumps, or automated insulin delivery systems, including during perioperative care and hospital discharge planning.
Read the original at Diabetes CareSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More endocrinology updates
- 2025 ATA thyroglobulin cutoff may miss recurrences in higher-risk DTCOct 13, 2026
- ADA-EASD 2026 consensus favors earlier SGLT2/GLP-1 use in type 2 diabetesOct 2, 2026
- Lean MASLD shows milder liver histology but similar clinical outcomesSep 30, 2026
- Oral GLP-1 agonist orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide Trial Shows Weight Loss and Comorbidity Benefits in ObesitySep 29, 2026